BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21091835)

  • 1. Frequent expression of gp46 in adult T-cell leukemia/lymphoma: an immunohistochemical study of 40 cases.
    Kiyasu J; Sagara Y; Kohno K; Sato K; Kimura Y; Hashikawa K; Takeuchi M; Niino D; Sugita Y; Takayanagi R; Abe Y; Ohshima K
    Pathol Int; 2010 Dec; 60(12):774-8. PubMed ID: 21091835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with HTLV-I-associated lymph node lesions.
    Ohshima K; Suzumiya J; Sato K; Kanda M; Simazaki T; Kawasaki C; Haraoka S; Kikuchi M
    J Pathol; 1999 Dec; 189(4):539-45. PubMed ID: 10629555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to the central region of human T-lymphotropic virus type 1 gp46 is associated with the progression of adult T-cell leukemia.
    Sagara Y; Inoue Y; Ohshima K; Kojima E; Utsunomiya A; Tsujimura M; Shiraki H; Kashiwagi S
    Cancer Sci; 2007 Feb; 98(2):240-5. PubMed ID: 17297657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
    Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
    Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide induces down-regulation of gp46 via protein oxidation: proteomics analysis of oxidative modified proteins in As2O3-treated HTLV-1-infected cells.
    Nabeshi H; Yoshikawa T; Kamada H; Shibata H; Sugita T; Abe Y; Nagano K; Nomura T; Minowa K; Tsunoda S; Tsutsumi Y
    Pharmazie; 2010 Sep; 65(9):702-7. PubMed ID: 21038850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
    J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic, immunophenotypic and ultrastructrual analyses of ATLL patients with cutaneous involvement.
    Wang C; Yao Z; Liao J; Luo Y; Ma Y; Chen G; Zhu W
    Chin Med J (Engl); 1999 May; 112(5):461-5. PubMed ID: 11593520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.
    Sagara Y; Inoue Y; Tsujimura M; Kojima E; Shiraki H; Kashiwagi S
    Cancer Sci; 2004 Oct; 95(10):835-9. PubMed ID: 15504252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult T-cell lymphoma/leukemia with angioimmunoblastic T-cell lymphomalike features: Report of 11 cases.
    Karube K; Suzumiya J; Okamoto M; Takeshita M; Maeda K; Sakaguchi M; Inada T; Tsushima H; Kikuchi M; Ohshima K
    Am J Surg Pathol; 2007 Feb; 31(2):216-23. PubMed ID: 17255766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.
    Takeoka H; Furusyo N; Toyoda K; Murata M; Sagara Y; Kashiwagi S; Hayashi J
    Am J Trop Med Hyg; 2007 Jul; 77(1):192-6. PubMed ID: 17620653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
    J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
    Bélec L; Georges-Courbot MC; Georges A; Mohamed AS; Londos-Gagliardi D; Hallouin MC; Hocini H; Guillemain B
    J Med Virol; 1996 Sep; 50(1):42-9. PubMed ID: 8890040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Foxp3 is associated with CD30 expression in the anaplastic large cell subtype of adult T-cell leukemia/lymphoma (ATLL) in US/Caribbean patients: potential therapeutic implications for CD30 antibody-mediated therapy.
    Yao J; Gottesman SR; Ayalew G; Braverman AS; Axiotis CA
    Am J Surg Pathol; 2013 Sep; 37(9):1407-12. PubMed ID: 23797717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1.
    Kaumaya PT; Conrad SF; DiGeorge AM; Lairmore MD
    Leukemia; 1995 Oct; 9 Suppl 1():S133-8. PubMed ID: 7475306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
    Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
    Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-1 and associated adult T-cell leukemia/lymphoma.
    Mahieux R; Gessain A
    Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.